Startseite A study on reference interval transference via linear regression
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

A study on reference interval transference via linear regression

  • Runqing Mu , Ke Yun , Xiaoou Yu , Shitong Cheng , Ming Ma , Xin Zhang , Shuo Wang , Min Zhao EMAIL logo und Hong Shang EMAIL logo
Veröffentlicht/Copyright: 27. Juli 2019
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background

Reference intervals (RIs) transference can expand the applicability of established RIs. However, the study on transference methodology is insufficient, and RIs validation based on small samples cannot adequately identify transferred risk under complex situations. This study aimed to find appropriate conditions to ensure the effect of transference.

Methods

We established the RIs of Roche and Beckman systems for 27 analytes based on 681 healthy individuals. Roche RIs were converted into the Beckman RIs using linear regression (least squares method) which is divided into two methods – Methodref (500 test numbers with relatively narrow data range) and Methodep (80 test numbers with relatively wide data range). Taking the RIs established by Beckman results as standard, we assessed the accuracy, precision and trueness of transferred results under various conditions.

Results

A total of 29.6% and 48.1% of analytes were consistent between the two systems for the lower and upper reference limits, respectively. The concordance rates between transferred and measured RIs for Methodref were up to 74.1% and 92.6%, which were better than Methodep (44.4% and 59.3%). The CV of transferred reference limits decreased gradually with increasing test number under the same data range. For most analytes, excluding some electrolyte tests, we could obtain accurate results when r > 0.800 and the test number was sufficient regardless of the regression equation types.

Conclusions

Transferability of RIs is affected by many factors, such as correlation, test number, regression equation type, and quality requirement. To reduce the risk of transference, it is very important to select right method with reasonable conditions.


Corresponding authors: Min Zhao, MD, PhD and Prof. Hong Shang (Laboratory Director), MD, PhD, Department of Laboratory Medicine, The First Hospital of China Medical University, National Clinical Research Center for Laboratory Medicine, 155 Nanjing Street North, Heping District, Shenyang, Liaoning 110001, P.R. China, Phone/Fax: +86-24-83282678

Acknowledgments

We thank the participants for their cooperation and sample contributions. We are grateful to all the staff members for taking part in this study. This study was supported by National Health Commission of the People’s Republic of China. This study was technical supported by Roche Diagnostics Ltd. and Beckman coulter Inc.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This study was supported by National Key Technologies R&D Program of China (2012BAI37B01) provided by the Ministry of Science and Technology of the People’s Republic of China, and Laboratory Medicine Innovation Unit (2019RU017) provided by Chinese Academy of Medical Sciences.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline – third edition. CLSI document C28-A3c. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.Suche in Google Scholar

2. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64:271–84.10.1080/00365510410006324Suche in Google Scholar PubMed

3. Ceriotti F, Henny J, Queralto J, Ziyu S, Ozarda Y, Chen B, et al. Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study. Clin Chem Lab Med 2010;48:1593–601.10.1515/CCLM.2010.315Suche in Google Scholar PubMed

4. Mu R, Chen W, Pan B, Wang L, Hao X, Huang X, et al. First definition of reference intervals of liver function tests in China: a large-population-based multi-center study about healthy adults. PLoS One 2013;8:e72916.10.1371/journal.pone.0072916Suche in Google Scholar PubMed PubMed Central

5. Chan AO, Lee KC, Leung JN, Shek CC. Reference intervals of common serum analytes of Hong Kong Chinese. J Clin Pathol 2008;61:632–6.10.1136/jcp.2007.053637Suche in Google Scholar PubMed

6. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854–68.10.1373/clinchem.2011.177741Suche in Google Scholar PubMed

7. Carlsson L, Lind L, Larsson A. Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology 2010;56:259–65.10.1159/000251722Suche in Google Scholar PubMed

8. Bevilacqua V, Chan MK, Chen Y, Armbruster D, Schodin B, Adeli K. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort. Clin Chem 2014;60:1532–42.10.1373/clinchem.2014.229799Suche in Google Scholar PubMed

9. Koerbin G, Cavanaugh JA, Potter JM, Abhayaratna WP, West NP, Glasgow N, et al. ‘Aussie normals’: an a priori study to develop clinical chemistry reference intervals in a healthy Australian population. Pathology 2015;47:138–44.10.1097/PAT.0000000000000227Suche in Google Scholar PubMed

10. CLSI. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline – Second Edition. CLSI document EP9-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2002.Suche in Google Scholar

11. Tate JR, Yen T, Jones GR. Transference and validation of reference intervals. Clin Chem 2015;61:1012–5.10.1373/clinchem.2015.243055Suche in Google Scholar PubMed

12. Lynch M, Thompson A, Gaumond B, Kilroy J, Leonard H, Jacob A, et al. Transference of reference intervals in the validation of automated chemiluminescent immunoassays on a new platform. Clin Chem 1998;44:2061–3.10.1093/clinchem/44.9.2061Suche in Google Scholar

13. Ghoshal AK, Soldin SJ. Evaluation of the Dade Behring Dimension R×L: integrated chemistry system-pediatric reference ranges. Clin Chim Acta 2003;331:135–46.10.1016/S0009-8981(03)00114-1Suche in Google Scholar

14. Estey MP, Cohen AH, Colantonio DA, Chan MK, Marvasti TB, Randell E, et al. CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem 2013;46:1197–219.10.1016/j.clinbiochem.2013.04.001Suche in Google Scholar PubMed

15. Abou El Hassan M, Stoianov A, Araujo PA, Sadeghieh T, Chan MK, Chen Y, et al. CLSI-based transference of CALIPER pediatric reference intervals to Beckman Coulter AU biochemical assays. Clin Biochem 2015;48:1151–9.10.1016/j.clinbiochem.2015.05.002Suche in Google Scholar PubMed

16. Araujo PA, Thomas D, Sadeghieh T, Bevilacqua V, Chan MK, Chen Y, et al. CLSI-based transference of the CALIPER database of pediatric reference intervals to Beckman Coulter DxC biochemical assays. Clin Biochem 2015;48:870–80.10.1016/j.clinbiochem.2015.06.002Suche in Google Scholar PubMed

17. Higgins V, Chan MK, Nieuwesteeg M, Hoffman BR, Bromberg IL, Gornall D, et al. Transference of CALIPER pediatric reference intervals to biochemical assays on the Roche Cobas 6000 and the Roche Modular P. Clin Biochem 2016;49:139–49.10.1016/j.clinbiochem.2015.08.018Suche in Google Scholar PubMed

18. Higgins V, Truong D, Woroch A, Chan MK, Tahmasebi H, Adeli K. CLSI-based transference and verification of CALIPER pediatric reference intervals for 29 Ortho VITROS 5600 chemistry assays. Clin Biochem 2018;53:93–103.10.1016/j.clinbiochem.2017.12.011Suche in Google Scholar PubMed

19. Ichihara K, Ceriotti F, Kazuo M, Huang YY, Shimizu Y, Suzuki H, et al. The Asian project for collaborative derivation of reference intervals: (2) results of non-standardized analytes and transference of reference intervals to the participating laboratories on the basis of cross-comparison of test results. Clin Chem Lab Med 2013;51:1443–57.10.1515/cclm-2012-0422Suche in Google Scholar PubMed

20. Ichihara K, Ozarda Y, Klee G, Straseski J, Baumann N, Ishikura K. Utility of a panel of sera for the alignment of test results in the worldwide multicenter study on reference values. Clin Chem Lab Med 2013;51:1007–25.10.1515/cclm-2013-0248Suche in Google Scholar PubMed

21. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Desirable specifications for total error, imprecision, and bias, derived from intra- and inter-individual biologic variation. Westgard website. Available: http://www.westgard.com/biodatabase1.htm. Accessed 2012.Suche in Google Scholar

22. Supak Smolcic V, Bilic-Zulle L, Fisic E. Validation of methods performance for routine biochemistry analytes at Cobas 6000 analyzer series module c501. Biochem Med (Zagreb) 2011;21:182–90.10.11613/BM.2011.028Suche in Google Scholar

23. Linnet K. Necessary sample size for method comparison studies based on regression analysis. Clin Chem 1999;45:882–94.10.1093/clinchem/45.6.882Suche in Google Scholar

24. Cornbleet PJ, Gochman N. Incorrect least-squares regression coefficients in method-comparison analysis. Clin Chem 1979;25:432–8.10.1093/clinchem/25.3.432Suche in Google Scholar

25. Passing H, Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983;21:709–20.10.1515/cclm.1983.21.11.709Suche in Google Scholar PubMed

26. CLSI. Measurement Procedure comparison and Bias Estimation Using Patient Samples; Approved Guideline – Third Edition. CLSI document EP09-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2013.Suche in Google Scholar

27. Lykkeboe S, Nielsen CG, Christensen PA. Indirect method for validating transference of reference intervals. Clin Chem Lab Med 2018;56:463–70.10.1515/cclm-2017-0574Suche in Google Scholar PubMed

Received: 2019-01-15
Accepted: 2019-07-03
Published Online: 2019-07-27
Published in Print: 2019-12-18

©2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Reflex TSH strategy: the good, the bad and the ugly
  4. Review
  5. Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review
  6. Mini Review
  7. Clinical application of presepsin as diagnostic biomarker of infection: overview and updates
  8. Opinion Paper
  9. Gut microbiotas and immune checkpoint inhibitor therapy response: a causal or coincidental relationship?
  10. EFLM Paper
  11. Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters
  12. General Clinical Chemistry and Laboratory Medicine
  13. Pre-, post- or no acidification of urine samples for calcium analysis: does it matter?
  14. Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis
  15. Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: a nested case control study
  16. Multi-site performance evaluation and Sigma metrics of 20 assays on the Atellica chemistry and immunoassay analyzers
  17. Plasma creatinine medians from patients partitioned by gender and age used as a tool for assessment of analytical stability at different concentrations
  18. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays
  19. Method comparison of four clinically available assays for serum free light chain analysis
  20. Comparison of three different chemiluminescence assays and a rapid liquid chromatography tandem mass spectrometry method for measuring serum aldosterone
  21. Repeatability and reproducibility of lipoprotein particle profile measurements in plasma samples by ultracentrifugation
  22. Reference Values and Biological Variations
  23. A study on reference interval transference via linear regression
  24. Cancer Diagnostics
  25. Unstimulated high-sensitive thyroglobulin is a powerful prognostic predictor in patients with thyroid cancer
  26. Cardiovascular Diseases
  27. Analytical validation of a highly sensitive point-of-care system for cardiac troponin I determination
  28. Acknowledgment
  29. Letters to the Editor
  30. Are icteric and lipemic indices reliable to screen for hyperbilirubinemia and hypertriglyceridemia?
  31. Anti-streptavidin antibodies as a cause of false-positive results of streptavidin-based autoantibody assays
  32. Assessment of complement interference in anti-Müllerian hormone immunoassays
  33. Validating thyroid-stimulating hormone (TSH) reflexive testing cutpoints in a tertiary care institution
  34. Results of the second external quality assessment for human papillomavirus genotyping in Shanghai, China
  35. Development of suitable external quality control material for G6PD deficiency screening with the fluorescent spot test
  36. Non-linearity in commercially available lipase assays: still gaps to close
  37. JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential
  38. Congress Abstracts
  39. 11th National Scientifc Congress SPML
Heruntergeladen am 16.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2019-0055/html
Button zum nach oben scrollen